Cytokine network in inflammatory bowel disease.
Disease states, such as those characterized by inflammation of the gastrointestinal tract (Crohn's disease and ulcerative colitis), are due to a host of factors that act in concert to produce pathologic change. The immunologic factors that mediate the development of such mucosal inflammation have been at the forefront of IBD research. Recently, a better understanding of the mechanisms involved in mucosal homeostasis and the occurrence of inflammatory bowel disease (IBD) has been achieved with the advent of animal models of mucosal inflammation. This review discusses these models and the insights they provide into the pathogenesis and regulation of IBD.
Fuss
Ivan J
IJ
Mucosal Immunity Section, National Institutes of Health, 10 center Dr, Build 10 Rm 11N238, Bethesda, MD 20892, USA. ifuss@niaid.nih.gov
D000818:Animals; D003092:Colitis / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D016207:Cytokines / Q000502:physiology*; D004195:Disease Models, Animal; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000473:pathology / Q000503:physiopathology*; D007413:Intestinal Mucosa / Q000473:pathology
D016207:Cytokines